Literature DB >> 9488663

Identification of Nore1 as a potential Ras effector.

D Vavvas1, X Li, J Avruch, X F Zhang.   

Abstract

The small GTP-binding protein Ras is pivotal in transmitting growth and differentiation signals downstream of cell surface receptors. Many observations have indicated that Ras transmits signals from cell surface receptors into multiple pathways via direct interaction with different effectors in mammalian cells. We have identified a novel potential Ras effector or target named Nore1. Nore1 has no significant sequence similarity to known mammalian proteins and lacks an identifiable catalytic domain, but contains sequence motifs that predict DAG_PE binding and SH3 domain binding. We show that Nore1 directly interacts with Ras in vitro in a GTP-dependent manner, and the interaction requires an intact Ras effector domain. Nore1 becomes associated with Ras in situ following activation of epidermal growth factor receptor in COS-7 and in KB cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488663     DOI: 10.1074/jbc.273.10.5439

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation.

Authors:  Christine Bee; Anna Moshnikova; Christopher D Mellor; Justin E Molloy; Yulia Koryakina; Benjamin Stieglitz; Andrei Khokhlatchev; Christian Herrmann
Journal:  J Biol Chem       Date:  2010-03-25       Impact factor: 5.157

2.  Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice.

Authors:  Dominic P Del Re; Takahisa Matsuda; Peiyong Zhai; Shumin Gao; Geoffrey J Clark; Louise Van Der Weyden; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

3.  Ras history: The saga continues.

Authors:  Adrienne D Cox; Channing J Der
Journal:  Small GTPases       Date:  2010-07

4.  NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis.

Authors:  Li-Li Liu; Mei-Fang Zhang; Ying-Hua Pan; Jing-Ping Yun; Chris Zhiyi Zhang
Journal:  Tumour Biol       Date:  2014-02-25

5.  RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.

Authors:  Wei Guo; Cong Wang; Yanli Guo; Supeng Shen; Xin Guo; Gang Kuang; Zhiming Dong
Journal:  Clin Exp Metastasis       Date:  2015-01-13       Impact factor: 5.150

6.  Improved binding of raf to Ras.GDP is correlated with biological activity.

Authors:  Christina Kiel; Daniel Filchtinski; Michael Spoerner; Gideon Schreiber; Hans Robert Kalbitzer; Christian Herrmann
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

Review 7.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

8.  The differential effects of wild-type and mutated K-Ras on MST2 signaling are determined by K-Ras activation kinetics.

Authors:  David Romano; Helene Maccario; Carolanne Doherty; Niall P Quinn; Walter Kolch; David Matallanas
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

9.  Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.

Authors:  Chang Kyun Lee; Jin-Hee Lee; Min-Goo Lee; Seong-In Jeong; Tae-Kyu Ha; Min-Ju Kang; Byung-Kyu Ryu; Young Hwangbo; Jae-Jun Shim; Jae Young Jang; Kil Yeon Lee; Hyo Jong Kim; Sung-Gil Chi
Journal:  BMC Cancer       Date:  2010-10-22       Impact factor: 4.430

10.  Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras.

Authors:  Maria Praskova; Andrei Khoklatchev; Sara Ortiz-Vega; Joseph Avruch
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.